[go: up one dir, main page]

AR068038A1 - Polipeptidos de la hormona de crecimiento modificada - Google Patents

Polipeptidos de la hormona de crecimiento modificada

Info

Publication number
AR068038A1
AR068038A1 ARP080103700A ARP080103700A AR068038A1 AR 068038 A1 AR068038 A1 AR 068038A1 AR P080103700 A ARP080103700 A AR P080103700A AR P080103700 A ARP080103700 A AR P080103700A AR 068038 A1 AR068038 A1 AR 068038A1
Authority
AR
Argentina
Prior art keywords
growth hormone
polypeptides
modified growth
proteins
fusion proteins
Prior art date
Application number
ARP080103700A
Other languages
English (en)
Original Assignee
Asterion Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asterion Ltd filed Critical Asterion Ltd
Publication of AR068038A1 publication Critical patent/AR068038A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se describen proteínas de fusion de la hormona de crecimiento modificada y dímeros que comprenden dichas proteínas de fusion; moléculas de ácido nucleico que codifican dichas proteínas y métodos de tratamiento que usan dichas proteínas en e! tratamiento de afecciones provenientes del exceso de hormona de crecimiento.
ARP080103700A 2007-10-10 2008-08-26 Polipeptidos de la hormona de crecimiento modificada AR068038A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97901007P 2007-10-10 2007-10-10
GBGB0719818.7A GB0719818D0 (en) 2007-10-11 2007-10-11 Growth hormone fusion polypeptides

Publications (1)

Publication Number Publication Date
AR068038A1 true AR068038A1 (es) 2009-10-28

Family

ID=38787949

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080103700A AR068038A1 (es) 2007-10-10 2008-08-26 Polipeptidos de la hormona de crecimiento modificada

Country Status (17)

Country Link
US (2) US8273552B2 (es)
EP (2) EP2886553A1 (es)
JP (1) JP5697983B2 (es)
KR (1) KR20100067686A (es)
CN (1) CN101932600B (es)
AR (1) AR068038A1 (es)
AU (1) AU2008309386A1 (es)
BR (1) BRPI0818639A2 (es)
CA (1) CA2701369A1 (es)
DK (1) DK2209798T3 (es)
ES (1) ES2532600T3 (es)
GB (1) GB0719818D0 (es)
IL (1) IL203073A0 (es)
MX (1) MX2010003892A (es)
RU (1) RU2471808C2 (es)
TW (1) TW200918098A (es)
WO (1) WO2009047474A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606946D0 (en) * 2006-04-06 2006-05-17 Asterion Ltd Polypeptide antagonist
GB201104285D0 (en) 2011-03-15 2011-04-27 Asterion Ltd Modified receptor fusion proteins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH20A (fr) * 1888-12-05 Joseph Magnat Une pompe à bière automatique fonctionnant par la pression de l'eau
CA2230492C (en) * 1995-09-21 2009-05-26 Genentech, Inc. Human growth hormone variants
GB0018891D0 (en) * 2000-08-01 2000-09-20 Novartis Ag Organic compounds
US7446183B2 (en) * 2000-06-16 2008-11-04 Asterion Limited Fusion protein comprising growth hormone and growth hormone receptor
US7704509B2 (en) * 2001-11-21 2010-04-27 United States Of America Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
GB2384001B (en) * 2001-12-14 2004-02-04 Asterion Ltd Chimeric growth hormone-growth hormone receptor proteins
JP2007527695A (ja) * 2003-04-09 2007-10-04 アステリオン・リミテッド グリコシルホスファチジルイノシトールを含有するポリペプチド
KR20090006221A (ko) * 2004-07-26 2009-01-14 아스테리온 리미티드 연결체들
GB0717985D0 (en) * 2007-07-20 2007-10-24 Asterion Ltd Growth hormone fusion proteins
JP2011512134A (ja) * 2008-02-19 2011-04-21 アステリオン・リミテッド 修飾リンカー

Also Published As

Publication number Publication date
RU2010103159A (ru) 2011-11-20
KR20100067686A (ko) 2010-06-21
US20120322735A1 (en) 2012-12-20
JP5697983B2 (ja) 2015-04-08
CN101932600B (zh) 2014-05-28
EP2209798A2 (en) 2010-07-28
TW200918098A (en) 2009-05-01
ES2532600T3 (es) 2015-03-30
WO2009047474A2 (en) 2009-04-16
CA2701369A1 (en) 2009-04-16
DK2209798T3 (en) 2015-03-23
EP2209798B1 (en) 2014-12-31
EP2886553A1 (en) 2015-06-24
WO2009047474A3 (en) 2010-09-02
JP2011507487A (ja) 2011-03-10
GB0719818D0 (en) 2007-11-21
CN101932600A (zh) 2010-12-29
BRPI0818639A2 (pt) 2015-04-07
US20100197589A1 (en) 2010-08-05
US8273552B2 (en) 2012-09-25
RU2471808C2 (ru) 2013-01-10
MX2010003892A (es) 2010-05-17
IL203073A0 (en) 2010-11-30
AU2008309386A1 (en) 2009-04-16

Similar Documents

Publication Publication Date Title
CY1124697T1 (el) Πρωτεϊνες συντηξης για τη θεραπεια διαταραχων του μεταβολισμου
UA113609C2 (xx) Антигензв'язуючий білок, який зв'язує людський il-23
UY33826A (es) Proteínas de unión con dominios trivariables y sus usos
EA201170242A1 (ru) Модифицированные бычьи полипептиды g-csf и их применение
PH12019500596B1 (en) Recombinant binding proteins and their use
EA201171148A1 (ru) Антитело-антагонист, специфичное для гетеродимера альфа-4-бета-7
AU2016240220B2 (en) Designed ankyrin repeat domains with binding specificity for serum albumin
MY206284A (en) Anti-cd63 antibodies, conjugates, and uses thereof
EA201400993A1 (ru) Антитела против рецептора эпидермального фактора роста, активные в определенных условиях, и способы их применения
CL2008001675A1 (es) Dominio variable simple (dab) de inmunoglobulina anti-factorde crecimiento endotelial vascular (vegf); acido nucleico que lo codifica; vector y celula huesped; metodo de produccion;antogonista de vegf que comprende el dab; composicion que comprende antogonista;y uso del antagonista para preparar un medicamento.
MX2024005945A (es) Polipeptidos que se unen al componente del complemento c5 o albumina serica y proteinas de fusion de los mismos.
EA201001204A1 (ru) Методы и композиции, в которых применяют слитые полипептиды klotho-fgf
PH12016500081A1 (en) Immunoglobulin variants and uses thereof
ECSP12011885A (es) Inmunoglobulinas con dominio variable dual
MX388739B (es) Casetes optimizados de expresión del gen humano del factor viii de coagulación y su uso.
JO3182B1 (ar) مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2
CL2012001504A1 (es) Proteinas de enlace a antigenos humanas porque induce la sensibilizacion mediada por factor 21 de crecimiento de fibroblastos (fgf21); acido nucleico que lo codifica; vector y celula aislada que comprenden el acido nucleico; metodo de produccion de dicha proteina.
CR11795A (es) Inmunoglobulinas con dominio variable dual y usos de las mismas
EA201500172A1 (ru) Модифицированные полипептиды фактора х и их применение
AR113492A2 (es) Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla
DK2086576T3 (da) H5-proteiner, nukleinsyremolekyler og vektorer kodende for disse, samt medicinsk anvendelse heraf
AR095418A1 (es) Métodos para aumentar el contenido de manosa en proteínas recombinantes
MX2011004483A (es) Leucolectinas y sus usos.
MX366178B (es) Proteinas de btnl3, acidos nucleicos, y anticuerpos y los usos de los mismos.
EA201290541A1 (ru) Модифицированные бычьи соматотропиновые полипептиды и их применение

Legal Events

Date Code Title Description
FA Abandonment or withdrawal